Top

Published in:

01-09-2020 | Gallbladder Cancer | ASO Author Reflections

ASO Author Reflections: Hepatopancreatoduodenectomy: Why, When, and How?

Authors: Calogero Iacono, MD, Mario De Bellis, MD, Alfredo Guglielmi, MD

Published in: Annals of Surgical Oncology | Issue 9/2020

Excerpt

Hepatopancreatoduodenectomy (HPD) is defined as a combined resection of the liver, extrahepatic bile ducts, and pancreatoduodenum. This aggressive surgery is performed to achieve curative resection in malignant biliary tumors extending into both the liver and the pancreas. In fact, R0 resection is the only treatment that can provide a chance for a cure. …

Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256(2):297–305. https://doi.org/10.1097/sla.0b013e31826029ca CrossRefPubMed

Souza MAD, Valdimarsson VT, Campagnaro T, et al. Hepatopancreatoduodenectomy: a controversial treatment for bile duct and gallbladder cancer from a European perspective. HPB (Oxford). Epub 30 Dec 2019. https://doi.org/10.1016/j.hpb.2019.12.008

Iacono C, De Bellis M, Ruzzenente A, Campagnaro T, Conci S, Guglielmi A. Hepatopancreatoduodenectomy for Multifocal Cholangiocarcinoma in the Setting of Biliary Papillomatosis. Ann Surg Oncol. Epub 4 Apr 2020. https://doi.org/10.1245/s10434-020-08357-1

Harada F, Matsuyama R, Mori R, et al. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: case–control study of a single Japanese institution’s experience with special attention to mucin expression patterns. Eur J Surg Oncol. 2019;45(5):761–768. https://doi.org/10.1016/j.ejso.2018.10.532 CrossRefPubMed

Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery 2013;153(6):794–800. https://doi.org/10.1016/j.surg.2012.11.024 CrossRef

Ito K, Sakamoto Y, Isayama H, et al. The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma. J Gastrointest Surg. 2018;22(9):1528–1537. https://doi.org/10.1007/s11605-018-3793-y CrossRefPubMed

Title: ASO Author Reflections: Hepatopancreatoduodenectomy: Why, When, and How?
Authors: Calogero Iacono, MD
Mario De Bellis, MD
Alfredo Guglielmi, MD
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Gallbladder Cancer
Gallbladder Cancer
Cholangiocarcinoma
Cholangiocarcinoma
Published in: Annals of Surgical Oncology / Issue 9/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-020-08569-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

ASO Author Reflections: Hepatopancreatoduodenectomy: Why, When, and How?

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2020

The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma

Intraoperative Surrogate Indicators of Gastric Cancer Patients’ Long-Term Prognosis: The Number of Lymph Nodes Examined Relates to the Lymph Node Noncompliance Rate

Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer

Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma

Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan

Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases